Tricyclic antidepressants for migraine and tension-type headaches

BMJ (Online)

Volumn 341, Issue 7778, 2010, Pages 841-

  Holroyd, Kenneth A ^a   Bendtsen, Lars ^b  

^a OHIO UNIVERSITY   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOMIPRAMINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VASODILATOR AGENT;

BODY WEIGHT; DROWSINESS; DRUG EFFICACY; EDITORIAL; HUMAN; MIGRAINE; PRIORITY JOURNAL; SIDE EFFECT; TENSION HEADACHE; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; HEADACHE DISORDERS; HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC;

EID: 78049273346     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c5250     Document Type: Editorial

References (11)

1. Jackson JL, Shimeall W, Sessums L, DeZee KJ, Becher D, Diemer M, et al. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ 2010;341:c5222.
2. Lance JW, Curran DA. Treatment of chronic tension headache. Lancet 1964;1:1236-9. [Medline]
3. Gomersall JD, Stuart A. Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychiatry 1973;36:684-90 [Abstract/FREE Full text]
4. Evers S, Afra J, Frese A, Goadsby P, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol 2009;16:968-81. [CrossRef] [Medline] [Web of Science]
5. Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J. EFNS guideline on the treatment of tension-type headache-report of an EFNS task force. Eur J Neurol2010; published online 11 May.
6. Ramadan N, Silberstein S, Freitag F, Gilbert T, Frishberg B. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for the prevention of migraine. American Academy of Neurology Guidelines, 2002, www.aan.com/professionals/practice/pdfs/gl0090.pdf.
7. Bendtsen L, Bigal M, Cerbo R, Diener H, Holroyd, Lampl C, et al. Guidelines for controlled trials of drugs in tension-type headache: second edition. Cephalalgia 2010;30:1-16. [Abstract/FREE Full text]
8. Tfelt-Hansen P, Block G, Dahlöf C, Diener H-C, Ferrari M, Goadsby P, et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000;20:765-86. [FREE Full text]
9. Holroyd K, Labus L, Carlson B. Moderation and mediation in the psychological and drug treatment of chronic tension-type headache: the role of disorder severity and psychiatric comorbidity. Pain 2009;143:213-22. [CrossRef] [Medline] [Web of Science]
10. Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson B. Management of chronic tension-type headache with tricyclic antidepressant medication, stress-management therapy, and their combination: a randomized controlled trial. JAMA 2001;285:2208-15. [Abstract/FREE Full text]
11. National Institutes of Health. NINDS Clinical Research Center. Chronic Migraine Treatment Trial. www.ninds.nih.gov/disorders/clinical-trials/ NCT00772031.htm.